E-Noses Promising for Diagnosing Cancer from Exhaled Breath

THURSDAY, June 30, 2022 (HealthDay News) -- Electronic noses (e-noses) appear to have a relatively high diagnostic accuracy in the detection of cancer from exhaled breath, according to a systematic review and meta-analysis published online June 29 in JAMA Network Open.
Max H.M.C. Scheepers, M.D., from Maastricht University in the Netherlands, and colleagues conducted a systematic literature review to identify studies evaluating the diagnostic accuracy and methodologic challenges of using e-noses for the detection of cancer.
Based upon 52 included feasibility studies (3,677 patients with cancer), the researchers found that the sensitivity of e-noses ranged from 48.3 to 95.8 percent and the specificity from 10.0 to 100.0 percent. Pooled analysis yielded a mean area under the receiver operating characteristic curve of 94 percent, a sensitivity of 90 percent, and a specificity of 87 percent. Differences in the selection of patients, endogenous and exogenous factors, and collection of exhaled breath resulted in considerable heterogeneity of the studies.
"Although e-noses were found to have promising accuracy in detecting cancer, there is a need for standardized external validation studies that evaluate their diagnostic accuracy so that their role in the diagnostic workup of cancer can be established," the authors write.
Related Posts
FDA Warns of Amoxicillin Shortage
MONDAY, Oct. 31, 2022 (HealthDay News) – It could be harder to fill a...
A los hogares de ancianos de EE. UU. les falta personal, y es peor en las comunidades minoritarias
LUNES, 15 de agosto de 2022 (HealthDay News) -- La escasez de personal en los...
Over 75,000 Kaiser Permanente Union Workers Could Strike on Wednesday
TUESDAY, Oct. 3, 2023 (HealthDay News) -- Health care workers who serve millions...
CDC Backs FDA Approval of Boosters for Those Aged 12 to 17 Years
THURSDAY, Jan. 6, 2022 (HealthDay News) -- The U.S. Centers for Disease Control...
